Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SafiledCriticalAventis Pharma Sa
Priority to CU1999068ApriorityCriticalpatent/CU22837A3/en
Publication of CU22837A3publicationCriticalpatent/CU22837A3/en
La invención tiene por objeto los compuestos de fórmula (I) en los cuales R, representa un radical alquilo eventualmente substituido ó (CH2)nAr, n, que representa un número entero que va de 0 a 6 y Ar que representa un radical arilo ó heteroarilo eventualmente substituido, y Z representa un átomo de hidrógeno ó el. resto de un ácido carboxílico. Los compuestos de fórmula (I) que presentan interesantes propiedades antibióticas.A subject of the invention is the compounds of formula (I) in which R represents an optionally substituted alkyl radical or (CH2) nAr, n, which represents an integer ranging from 0 to 6 and Ar representing an aryl radical or optionally substituted heteroaryl, and Z represents a hydrogen atom or the. rest of a carboxylic acid. The compounds of formula (I) that have interesting antibiotic properties.
CU1999068A1999-06-081999-06-08
NEW DERIVATIVES OF ERYTHROMYCIN, ITS PREPARATION PROCEDURE AND ITS APPLICATION AS MEDICATIONS
CU22837A3
(en)
BENZO DERIVATIVES (B) TIEPIN-1,1, -DIOXIDE, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS, PROCEDURE FOR PREPARATION OF MEDICINES AND THEIR EMPLOYMENT FOR PREPARATION OF MEDICINES.